rapamycin → P53 — Novel Hypothesis | InTree.AI

Novel Hypothesis

rapamycinP53

Rapamycin activates p53 through mTORC1 inhibition and reduced MDM2 stabilization in p53-wild-type cancers.

Convergence: 75%3 bridgesoncology

Bridge Entities

MDM2A→B quality: 0.70B→C quality: 0.70

rapamycin PARTICIPATES IN MDM2, which CONNECTED TO P53

A→B Evidence (4 total)

“P53-Mdm2 Loop Stability and Oscillatory Dynamics with Mdm2-Induced Delay Effect in P53”— P53-Mdm2 Loop Stability and Oscillatory Dynamics with Mdm2-Induced Delay Effect in P53 (2021)DOI

HCT116A→B quality: 0.50B→C quality: 0.50

rapamycin CO MENTIONED WITH HCT116, which CO MENTIONED WITH P53

EVOA→B quality: 0.50B→C quality: 0.50

rapamycin CO MENTIONED WITH EVO, which CO MENTIONED WITH P53

Why This Is Novel

The rapamycin–P53 connection is partially studied (131 co-occurrences), but the MDM2-mediated mechanism may represent a less-explored angle within this relationship.

Discovered by InTree.AI — analyzing 250M+ scientific papers